James L Heppell Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

James Heppell SPHS stock SEC Form 4 insiders trading

James has made over 1 trades of the Sophiris Bio Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently James sold 19,231 units of SPHS stock worth $49,808 on 6 June 2014.

The largest trade James's ever made was selling 19,231 units of Sophiris Bio Inc stock on 6 June 2014 worth over $49,808. On average, James trades about 1,282 units every 0 days since 2005.

You can see the complete history of James Heppell stock trades at the bottom of the page.

What's James Heppell's mailing address?

James's mailing address filed with the SEC is 1258 Prospect St, La Jolla, CA 92037, USA.

Insiders trading at Sophiris Bio Inc

Over the last 11 years, insiders at Sophiris Bio Inc have traded over $592,052 worth of Sophiris Bio Inc stock and bought 1,642,180 units worth $8,144,540 . The most active insiders traders include Capital, Llc Boxer Asset Ma..., Capital, Llc Boxer Asset Ma..., and William R Rohn. On average, Sophiris Bio Inc executives and independent directors trade stock every 155 days with the average trade being worth of $0. The most recent stock trade was executed by Randall E Woods on 19 September 2018, trading 10,000 units of SPHS stock currently worth $26,300.

What does Sophiris Bio Inc do?

Complete history of James Heppell stock trades at Inovio Pharmaceuticals Inc and Sophiris Bio Inc

Sophiris Bio Inc executives and stock owners

Sophiris Bio Inc executives and other stock owners filed with the SEC include:

• Randall Woods,
  President, Chief Executive Officer, Director
• Allison Hulme,
  Director
• Randall E. Woods,
  Pres, CEO & Director
• Peter Slover,
  Chief Financial Officer
• Lars Ekman,
  Chairman of the Board
• Gerald Proehl,
  Independent Director
• John Geltosky,
  Independent Director
• Iain R. Mant Esq.,
  Corp. Sec.
• Dr. James Joseph Beesley,
  Sr. Director of Investor Relations
• Dr. Samuel R. Denmeade M.D.,
  Chief Scientific Officer & Member of the Scientific Advisory Board
• James L Heppell,
  Director
• Joseph L Turner,
  Director
• Capital, Llc Boxer Asset Ma...,
  
• William R Rohn,
  Director
• Capital, Llc Boxer Asset Ma...,